TrialGenome biology2007

Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection.

Monica C Panelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.